Selective depletion of CD169+ macrophages inCD169-DTR mice has been shown to lead to the amelioration of psoriasis symptoms, accompanied by reduced levels of proinflammatory cytokines and a lower proportion of Th17 cells in the skin lesions. The gene discussed is SIGLEC1; the disease is psoriasis.